- FATE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Fate Therapeutics (FATE) 8-K30 Jun 22ONO to Contribute Novel Binding Domains for a Second Solid Tumor Antigen to the CollaborationFinancial data
Company Profile